Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
15.218 / 17.019
#121737

Re: Farmas USA

Solofarmas si tienes amigos en los broker ...va a ser que si .


#121738

Re: Farmas USA

Hice lo mismo con JNJ.
#121739

Re: Farmas USA

BCRX
Me saltó stop en 2,63. Bueno saqué como un 30% de pluses, aunque metí poco. Parece que la están sujetando en este rango de precios, algo traman
#121740

Re: Farmas USA

BCRX

Ya lo veo.....a ver si van a sacar alguna PR en afters o mañana en pre que la catapulte...
A lo mejor pillo unas pocas otra vez antes del cierre...
Yo esperaba que cayera más ante la falta de news en la conferencia....
Pero está el tema del vencimiento del viernes...

Un saludo
#121743

Re: Farmas USA

 

IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea

April 16, 2020 
- The Coalition for Epidemic Preparedness Innovations (CEPI) grants $6.9 million funding to INOVIO and IVI to conduct clinical testing in Korea for INOVIO's COVID-19 vaccine candidate based on their well-established DNA platform technology

INOVIO's DNA vaccine platform is also utilized in their MERS vaccine, INO-4700, for which IVI previously conducted Phase I clinical testing with GeneOne Life Science in South Korea..

 This news follows the announcement from the Korean Ministry of Food and Drug Safety made on April 13th that they will adopt a fast-track approval process for COVID-19 vaccine and treatment clinical trials. The period of clinical trial screening will be shortened to seven days (down from 30 days

 Additionally, vaccines developed with a proven safety platform, such as INOVIO's DNA platform, will be exempt from toxicology tests which will minimize data submission and expedite clinical trials.

 http://ir.inovio.com/news-and-media/news/press-release-details/2020/IVI-INOVIO-and-KNIH-to-Partner-with-CEPI-in-Phase-12-Clinical-Trial-of-INOVIOs-COVID-19-DNA-Vaccine-in-South-Korea/default.aspx 


#121744

Re: Farmas USA

  Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine 
 
Apr 16, 2020 at 7:30 AM EDT
  • The collaboration will combine Dynavax’s CpG 1018, the adjuvant contained in U.S. FDA-approved HEPLISAV-B vaccine, with Sinovac’s chemically inactivated coronavirus vaccine candidat
Te puede interesar...

- No hay entradas a destacar -

- No hay entradas a destacar -